Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating DA-1229 for efficacy and safety in calcific aortic valve disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcific Aortic Valve Disease

Drugs mentioned

• DA-1229 (DA-1229)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Calcific Aortic Valve Disease | Phase 2 | Status: COMPLETED